147 related articles for article (PubMed ID: 19237015)
41. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
Bosi E
Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
[TBL] [Abstract][Full Text] [Related]
42. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.
Kim WS; Lee YS; Cha SH; Jeong HW; Choe SS; Lee MR; Oh GT; Park HS; Lee KU; Lane MD; Kim JB
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E812-9. PubMed ID: 19176354
[TBL] [Abstract][Full Text] [Related]
43. Pharmacodynamic-pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models.
Adikwu MU; Yoshikawa Y; Takada K
Biomaterials; 2004 Jul; 25(15):3041-8. PubMed ID: 14967537
[TBL] [Abstract][Full Text] [Related]
44. DBM mice as a pharmacological model of maturity onset diabetes. Studies with metformin.
Junien JL; Brohon J; Guillaume M; Sterne J
Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):165-76. PubMed ID: 526068
[TBL] [Abstract][Full Text] [Related]
45. Effect of saponins from Helicteres isora on lipid and glucose metabolism regulating genes expression.
Bhavsar SK; Singh S; Giri S; Jain MR; Santani DD
J Ethnopharmacol; 2009 Jul; 124(3):426-33. PubMed ID: 19505560
[TBL] [Abstract][Full Text] [Related]
46. [Experimental study on antidiabetic effect of the total flavonoids in Leucaena seeds].
Li XJ; Deng JG; Qin ZL; Huang HB
Zhongguo Zhong Yao Za Zhi; 2005 Jun; 30(11):842-4. PubMed ID: 16110867
[TBL] [Abstract][Full Text] [Related]
47. Screening for antidiabetic activities.
Caccetta R; Al Salami H
Methods Mol Biol; 2013; 1055():207-18. PubMed ID: 23963913
[TBL] [Abstract][Full Text] [Related]
48. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
[TBL] [Abstract][Full Text] [Related]
49. Study on the antidiabetic mechanism of a shark liver peptide, S-8300, in alloxan-induced diabetes.
Huang F; Wu W
J Pharm Pharmacol; 2009 Jun; 61(6):789-94. PubMed ID: 19505370
[TBL] [Abstract][Full Text] [Related]
50. Experimental rodent models of type 2 diabetes: a review.
Islam MS; Loots du T
Methods Find Exp Clin Pharmacol; 2009 May; 31(4):249-61. PubMed ID: 19557203
[TBL] [Abstract][Full Text] [Related]
51. Hypoglycemic activity of a polyphenolic oligomer-rich extract of Cinnamomum parthenoxylon bark in normal and streptozotocin-induced diabetic rats.
Jia Q; Liu X; Wu X; Wang R; Hu X; Li Y; Huang C
Phytomedicine; 2009 Aug; 16(8):744-50. PubMed ID: 19464860
[TBL] [Abstract][Full Text] [Related]
52. Effect of chronic co-administration of metformin and vitamin C on plasma glucose and lipid concentrations in normal rats.
Adeneye AA; Amole OO; Agbaje EO; Izegbu MC; Elias SO
Afr J Med Med Sci; 2007 Jun; 36(2):149-54. PubMed ID: 19205578
[TBL] [Abstract][Full Text] [Related]
53. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
[TBL] [Abstract][Full Text] [Related]
54. Increased turnover of surface insulin receptors in fibroblastic cultures from genetically diabetic (DB/DB) mice.
Kadle R; Raizada MK; Fellows RE
J Cell Biochem; 1985; 28(1):59-67. PubMed ID: 3897251
[TBL] [Abstract][Full Text] [Related]
55. Diabetes in mice with monogenic obesity: the db/db mouse and its use in the study of cardiac consequences.
Belke DD; Severson DL
Methods Mol Biol; 2012; 933():47-57. PubMed ID: 22893400
[TBL] [Abstract][Full Text] [Related]
56. Assessment of genomic instability in normal and diabetic rats treated with metformin.
Attia SM; Helal GK; Alhaider AA
Chem Biol Interact; 2009 Jul; 180(2):296-304. PubMed ID: 19497428
[TBL] [Abstract][Full Text] [Related]
57. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
Kalaiarasi P; Kaviarasan K; Pugalendi KV
Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
[TBL] [Abstract][Full Text] [Related]
58. Tetrathiomolybdate is partially protective against hyperglycemia in rodent models of diabetes.
Zeng C; Hou G; Dick R; Brewer GJ
Exp Biol Med (Maywood); 2008 Aug; 233(8):1021-5. PubMed ID: 18480419
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of coumarin on hepatic key enzymes of glucose metabolism in chemical induced type 2 diabetic rats.
Pari L; Rajarajeswari N
Chem Biol Interact; 2009 Oct; 181(3):292-6. PubMed ID: 19647726
[TBL] [Abstract][Full Text] [Related]
60. Antihyperlipidemic effect of Garlip, a polyherbal formulation in streptozotocin induced diabetic rats.
Sharmila Banu G; Kumar G; Murugesan AG
Food Chem Toxicol; 2009 Sep; 47(9):2361-5. PubMed ID: 19555732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
